ArticleLung cancer (Amsterdam, Netherlands)2025
Nonagenarians: Outcomes after lung cancer surgery.
Article in Lung cancer (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Frailty in patients undergoing video-assisted thoracoscopic surgery for lung cancer: a narrative review of assessment, outcomes and prehabilitation.World journal of surgical oncology · 2026Review
- Surgical outcomes and quality of life in octogenarians with early-stage non-small cell lung cancer: a prospective cohort study.Lancet regional health. Americas · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionAn increasing number of nonagenarians are being referred to thoracic surgery clinics for the treatment of non-small cell lung cancer (NSCLC). However, discussions with the patient about surgical resection as a treatment option and the related informed consent process are constrained by the lack of specific information regarding perioperative and short- and long-term outcomes after surgery in this cohort of patients.
methodsWe retrospectively identified patients aged ≥90 years who underwent surgical resection for NSCLC at Memorial Sloan Kettering Cancer Center from 2001 to 2021. Risks, complications, and outcomes related to surgical treatment, including neurocognitive complications, length of stay, readmissions, mortality, and survival, were assessed.
resultsDuring the study period, 17 nonagenarian patients underwent surgical resection for NSCLC at our center; 15 of these patients (88%) received geriatric and/or cardiology consultation before surgery. Fourteen patients (82%) experienced minor complications; however, evidence of postoperative neurocognitive status compromise was not observed. Median length of stay was 5 days; 3 patients (18%) were readmitted within 90 days of discharge. No patients died within 30 or 90 days of surgical resection. Median overall survival was 43 months.
conclusionsOutcomes among nonagenarian patients who were selected to undergo surgical resection for NSCLC were positive, with overall survival approaching that of the general population of 90-year-olds. The data from this study can enrich the informed consent discussion with nonagenarian patients who are candidates for surgical resection for NSCLC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.